Related Stories

• Single dose HIV DNA vaccine induces long lasting immune response in monkeys
  
For the first time researchers from the U.S. and abroad have shown a single-dose HIV DNA vaccine can induce a long-lasting HIV-specific immune response in nonhuman primates, a discovery that ...
• Single dose H5N1 vaccine safe and effective in adults and elderly
  
Researchers from Hungary and the UK have developed a single-dose H5N1 influenza vaccine that induces a protective level of immunity against infection in healthy adult and elderly volunteers. The vaccine ...
• Astrogenetix Continues MRSA Vaccine Development Onboard Endeavor
  
Space Shuttle Endeavor lifted off from NASA’s Kennedy Space Center this morning, carrying on board the eighth scientific payload for Astrogenetix, a commercial biotech company created to use microgravity to ...
• Circassia Achieves Positive Phase II Clinical Results With Ragweed Allergy T Cell Vaccine
  
Press releases distributed via CNW Group.
• New vaccine could be lethal weapon against malaria cholera
  
Mankind may finally have a weapon to fight two of the world's deadliest diseases. A biomedical researcher has developed what promises to be the first low-cost dual vaccine against malaria ...
• Malaria vaccine three years off
  
Microsoft founder Bill Gates tells the BBC that a partially effective vaccine for malaria could be just three years away.
• New Vaccine for Pneumococcal Disease Receives Priority Approval From Health Canada
  
Press releases distributed via CNW Group. VANCOUVER, Dec. 22 /CNW/ - Perfora Investments S.a.r.l. ("Perfora") announces that it has acquired 12,750,000 shares (the "Shares") of Comaplex Minerals Corp. ("Comaplex") pursuant ...
• AMP Receives dollor 1.4 Million Grant From the Bill and Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa
  
Press releases distributed via CNW Group. STETTLER, AB, Dec. 8 /CNW/ - <<
• Vitamin D might be just as important as vaccine to prevent effects of H1N1 swine flu researchers say
  
Press releases distributed via CNW Group. BLAINE, WA, Nov. 26 /CNW/ - Century Mining Corporation (CMM: TSX-V) today announced that, subject to regulatory approval, it will complete a non-brokered private ...
• AFFiRiS AG Decision to Move Alzheimers Vaccine Candidate AD02 into Clinical Phase II Testing
  
Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing